PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Jun-2022 Insights on the Bone Grafts & Substitutes Global Market to 2027 - Increasing Demand from Orthopedic Surgeries Presents Opportunities - ResearchAndMarkets.com Businesswire
06-Jun-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Jun-2022 Global Genetic Disorders Partnering Deals Directory 2022: Access to Deals Signed by the World's Leading Pharmaceutical and Biotechnology Companies Since 2015 - ResearchAndMarkets.com Businesswire
06-Jun-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Jun-2022 United Therapeutics Provides an Update on Its Organ Printing Programs Businesswire
06-Jun-2022 Worldwide Allergen Blocker Industry to 2027 - Increasing Number of People Having Allergies and Adoption of Pets are Driving Growth - ResearchAndMarkets.com Businesswire
06-Jun-2022 Worldwide Medical Animation Industry to 2027 - Cardiology Is a Promising Field for Medical Animation/Simulation - ResearchAndMarkets.com Businesswire
06-Jun-2022 AWS and HKSTP Announce Strategic Collaboration to Accelerate Innovation and Technology Development in Hong Kong Businesswire
06-Jun-2022 Global Medical Writing Market Growth Trends and Forecasts 2022-2030: Robust Growth in CRO Outsourcing, Rapid Innovations in the Field of Oncology Drug Development - ResearchAndMarkets.com Businesswire
06-Jun-2022 Qualis Innovations Inc. Becomes Fully Reporting Company Newswire
06-Jun-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
06-Jun-2022 Transgene Presented Additional Phase I Data with TG4050 (myvac® platform) at ASCO 2022 Businesswire
05-Jun-2022 Updated Data for Janssen’s Bispecific Teclistamab Suggest Continued Deep and Durable Responses in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Businesswire
05-Jun-2022 NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications Businesswire
05-Jun-2022 NOXXON Presents Full Top-line Results From NOX-A12 Phase 1/2 GLORIA Trial in Glioblastoma at the 2022 ASCO Annual Meeting Businesswire
05-Jun-2022 Foundation Medicine Announces Strategic Collaboration with Arvinas Businesswire
05-Jun-2022 Adjuvant Treatment With Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Statistically Significant & Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients With Resected Stage IIB or IIC Melanoma in Phase 3 KEYNOTE-716 Trial Businesswire
05-Jun-2022 Creatv Bio’s LifeTracDx® Liquid Biopsy Predicts Response to New Line of Therapy for Metastatic Breast Cancer within 30 Days Businesswire
04-Jun-2022 MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022 Businesswire
04-Jun-2022 CG Oncology Presents New Clinical Data on Two Ongoing Programs at The American Society of Clinical Oncology (ASCO) 2022 Annual Meeting Businesswire